У нас вы можете посмотреть бесплатно Cancer Survivor Story: My Successful Targeted Therapy Treatment | Ashley's Story (2 of 3) или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
In this segment, Ashley shares how she was able to land on a newly FDA-approved targeted treatment (osimertinib or Tagrisso) that allowed her to skip chemotherapy through an IV at the hospital and instead, take a daily pill. She shares how she was able to get such a new drug approved through her insurance, her follow-up schedule with her oncologist, and delves also into the side effects and how she’s been able to get through them as best as she can every day. Navigation → see below for time codes to different subsections. In this Series: Our 3-part series with Ashley covers her from how she got diagnosed, to the targeted therapy that had just been approved for her cancer subtype and genetic mutation (EGFR+ T790M) that allowed her to take a pill (osimertinib or Tagrisso) instead of traditional chemotherapy, through how she lives with her incurable but treatable disease. Full story & transcript →https://www.thepatientstory.com/patie... The interview has only been edited for clarity. Join Our Community: Website : https://www.thepatientstory.com/ Facebook: @ThePatientStory Instagram: @ThePatientStory Twitter: @patient_story ______________________________ Contents of this video: 0:00 - Intro: Treatment & Testing 0:57 - Describe the scan of your lungs 1:59 - Deciding where to get treatment 4:48 - The Genomic Testing 11:42 - Targeted Therapy (osimertinib) Schedule 13:07 - Dealing with side effects 21:45 - Giving yourself Grace 25:28 - Experience of brand new treatment 31:49 - Monitoring schedule with oncologist ______________________________ #LungCancer #Cancer #ThePatientStory #egfr #genomictesting #clinicaltrials #targetedtherapy #osimertinib #tagrisso #astrazeneca